...as managing director at C-Bridge Capital (now CBC Group...

...saw participation from the company’s founding investor, CBC Group...
...employees: 80Funds raised: At least $170 millionInvestors: CBC Group...
...Dayao ZhaoPatents: N/A Jeff Cranmer AffaMed Therapeutics (Shanghai) Co. Ltd. CBC Group Lake...

...past nine years at bluebird bio Inc. (NASDAQ:BLUE), will be stepping down on April 16. Investment firm CBC Group...
...and general counsel at Sarepta Therapeutics Inc. (NASDAQ:SRPT). Gunjan Ohri Agilent Technologies Inc. Turning Point Therapeutics Inc. Moderna Inc. CareDx Inc. CBC Group Intercept...

...for $300M fund brings in royalty streams for Paratek’s Nuzyra By Paul Bonanos, Associate Editor CBC Group...
...New York, Shanghai, Hong Kong and Beijing. Paul Bonanos Nuzyra, omadacycline (ZL-2401, ptk 0796, BAY 73-7388, MK-2764, PTK796) CBC Group Paratek...

...series D round led by RTW Investments and GT Fund with participation by existing investors CBC Group...

...and Co. (NYSE:LLY), Blanchard was with Innovent for about 18 months in 2018-19. He joined CBC Group...
...including those in its $310 million series C round in June, also participated in the IPO.CBC Group...

...C-2 equity round, which also included RA Capital, Hillhouse Capital, Decheng Capital, ZJMF, Janus Henderson, CBC Group...
...Lilly and Co. (NYSE:LLY), was CSO at Innovent Biologics Inc. (HKSE:1801) in 2018-19 before joining CBC Group...

...board, succeeds interim CEO Sean Cao. Blanchard was an operating partner at Everest’s founding investor CBC Group...
...as CSO of Innovent Biologics Inc. (HKEX:1801). Cao, who is also a managing director at CBC Group...

...retiring, as CFO. Cooper was finance director at Kennet Partners Ltd. Kerry Blanchard has joined CBC Group...
...Inc. Verseau Therapeutics Inc. Flagship Pioneering Inozyme Pharma Inc. Theragnostics Ltd. Prescient Medicine Holdings Inc. Orion Biotechnology Canada Ltd. Arrowhead Pharmaceuticals Inc. Abingworth LLP CBC Group Diverse...

...In China, 3SBio Inc. (HKSE:1530) holds rights to SB8, a biosimilar of Avastin bevacizumab, while CBC Group...